Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.01 (+0.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Debt Ratio (2024 - 2026)

Updated

Drugs Made In America Acquisition's Debt Ratio was 0.00 in Q2 2026.

Analysis

Drugs Made In America Acquisition (DMAA) Debt Ratio (2024 - 2026) Analysis & Trends

For FY2024, Debt Ratio at Drugs Made In America Acquisition came in at 1.20.

  • The Q2 2026 figure marks the highest quarterly Debt Ratio since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - -
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - 0.26
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn 0.96
5 Kkr 81.05 Bn 47.53 Bn - -
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - 0.17
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn -
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 0.00
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn -
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2025 0.00
Dec 31, 2024 1.20
API Access

Drugs Made In America Acquisition Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=DMAA&period=max&api_key=YOUR_API_KEY